Developer of Living Technology™ Reaches 100th Sale of Flagship Resona 7 Ultrasound System while Achieving Double Digit Growth Year Over Year
Mahwah, New Jersey – September 3, 2019 – Mindray, a global developer of next generation medical devices and software, today announced the sale of its 100th flagship Resona 7 Ultrasound System in North America to Hillcrest Medical Center in Tulsa, Oklahoma, a leading healthcare provider for the region. The company also indicates it has experienced double digit growth in North America year over year due to the growing demand for its ultrasound imaging solutions.
“Our Resona 7 System has rapidly gained acceptance from leading healthcare providers with more than 2,000 systems installed worldwide,” said Maher Elhihi, director, ultrasound marketing, Mindray. Elhihi continued, “According to the industry-leading Klein Biomedical Consultants’ 2018 report on the Medical Diagnostic Ultrasound Market in the USA, ultrasound revenues grew 10 percent in 2018 for the U.S. With these sales milestones, our ultrasound business outpaced the market growth and Mindray North America became one of the top four largest ultrasound suppliers in the U.S. per the Klein report.”
Powered by ZONE Sonography® Technology+ (ZST+), the Resona 7 Ultrasound System Sapphire Edition is designed to address the changing needs of today’s value-based healthcare environment. The system delivers crystal clear imaging with unrivaled detail resolution and image uniformity coupled with the industry’s best investment protection. In addition, based on Mindray’s Living Technology™, which enables easily upgradable ultrasound enhancements and applications as they are developed, the Resona 7 System includes five years of software updates to ensure that Mindray’s customers remain at the cutting-edge of imaging performance.
“A key factor in choosing the Resona 7 System was the ongoing upgrades Mindray continues to develop,” said Suzanne Bean, supervisor of ultrasound at Hillcrest. “This helps us to remain at state-of-the-art imaging while protecting our investment in the future. It provides an excellent value proposition along with superb imaging capabilities, supporting excellence in patient care.”